ENVB soars 134% as market reacts to private placement closing and warrant-driven trading dynamics

By: Quiver PriceTracker

Posted: 6 days, 23 hours ago / April 20, 2026 3:14 p.m. UTC

ENVB

Enveric Biosciences (ENVB) is up 134.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The outsized move appears tied to renewed trading interest after the company announced the closing of its at-the-market private placement, which included a large warrant package. After the financing-related selloff late last week, today’s jump also looks consistent with short-covering and momentum buying in a low-priced, small-cap biotech.

Details:

The company announced it closed a private placement featuring 2,222,223 common shares (or pre-funded warrants in lieu thereof) alongside Series I and Series J warrants for up to an aggregate of 2,222,223 shares each.

The stated purchase price was $2.25 per share (or pre-funded warrant), with warrants exercisable immediately at $2.00 per share.

Gross proceeds were approximately $5.0 million upfront, with up to approximately $8.9 million of additional potential proceeds if warrants are exercised in full (no assurance of exercise was provided).

An SEC filing described registration-rights commitments and disclosed the private placement closed on April 17, 2026, which can influence near-term liquidity expectations and trading behavior.

Sources:

Enveric Biosciences (press release), SEC (Form 8-K), StreetInsider

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$ENVB Hedge Fund Activity

We have seen 9 institutional investors add shares of $ENVB stock to their portfolio, and 4 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS GROUP AG removed 5,883 shares (-67.0%) from their portfolio in Q4 2025, for an estimated $21,355
GEODE CAPITAL MANAGEMENT, LLC removed 2,375 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $8,621
CITIGROUP INC added 2,276 shares (+inf%) to their portfolio in Q4 2025, for an estimated $8,261
CITADEL ADVISORS LLC removed 1,889 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $6,857
TOWER RESEARCH CAPITAL LLC (TRC) added 1,716 shares (+853.7%) to their portfolio in Q4 2025, for an estimated $6,229
BANK OF AMERICA CORP /DE/ added 3 shares (+150.0%) to their portfolio in Q4 2025, for an estimated $10
WELLS FARGO & COMPANY/MN added 1 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.